Mobile

A Phase II open label randomized parallel group non comparative trial to assess efficacy and safety of the association of IPH1101 and IL-2 alone and in combination with dacarbazine, in patients with m...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-007265-20

A Phase II open label randomized parallel group non comparative trial to assess efficacy and safety of the association of IPH1101 and IL-2 alone and in combination with dacarbazine, in patients with metastatic melanoma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to assess the efficacy of IPH1101/IL-2 in monotherapy and in combination with Dacarbazine in advanced melanoma patients.

Critère d'inclusion

  • Metastatic melanoma

Liens